Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori

Acta Pharmaceutica

Volumn 57, Issue 4, 2007, Pages 413-427

  Rajinikanth, Parauvathanahalli Siddalingam ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Acetohydroxamic acid; Controlled release; Floating drug delivery; Gellan beads; Helicobacter pylori; Stomach specific delivery

Indexed keywords

ACETOHYDROXAMIC ACID; CALCIUM CARBONATE; CHITOSAN; GELLAN; GELLAN BEAD; POLYMER; UNCLASSIFIED DRUG; UREASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; ERADICATION THERAPY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; KINETICS; MICROMORPHOLOGY; NONHUMAN;

EID: 37649025645     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0033-5     Document Type: Article

References (23)

1. A. Rubinstein and D. R. Friend, Site-specific Delivery to the Gastrointestinal Tract, in Polymeric Site-Specific Pharmacotherapy (Ed. A. J. Domb), Wiley, Chichester 1994, pp. 267-313.
2. N. Nagahara, Y. Akiyama, M. Tada, M. Nakao, M. Kitano and Y. Ogawa, Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori, Antimicrob. Agents Chemother. 42 (1998) 2492-2494.
3. R. Hejazi and M. Amiji, Stomach-specific anti-H. pylori therapy. I. Preparation and characterization of tetracycline-loaded chitosan microspheres, Int. J. Pharm. 235 (2002) 87-94; DOI: 10. 1016/S0378-5173(01) 00985-1.
4. R. B. Umamaheshwari, S. Jain and N. K. Jain, A new approach in gastroretentive drug delivery system using cholestyramine, Drug Deliv. 10 (2003) 151-160; DOI: 10.1080/713840399.
5. B. J. Marshall and J. R. Warren, Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration, Lancet 1 (1984) 1311-1315; DOI: 10.1016/S0140-6736(84)91816-6.
6. P. S. Rajinikanth, J. Balasubramanium and B. Mishra, Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradicating of Helicobacter pylori, Int. J. Pharm. 335 (2007) 114-122; DOI: 10.1016/j.ijpharm.2006.11.009.
7. C. K. Lin, P. I. Hsu and K. H. Lai, One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy, J. Clin. Gastroenterol. 34 (2002) 547-551.
8. R. B. Umamaheshwari, R. Suman and N. K. Jain, Anti Helicobacter pylori effect of mucoadhesive nanoparticle bearing amoxicillin in experimental gerbils, APPS Pharm. Sci. Tech. 5 (2004) article 32.
9. A. M. El. Nujumi, C. A. Dorrian, R. S. Chittajallu, W. D. Neithercut, K. E. L. McColl, Effect of inhibition of Helicobacter pylori urease activity of acetohydroxamic acid on serum gastrin in duodenal ulcer subjects, Gut 32 (1991) 866-870.
10. H. L. Mobley, L. T. Hu and P. Foxall, Helicobacter pylori urease: Properties and role in pathogenesis, Scand. J. Gastroenterol. Suppl. 187 (1991) 39-46.
11. S. H. Phadnis, M. H. Parlow, M. Levy, D. Iher, C. M. Canldine, J. B. Connors and B. E. Dunn, Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis, Infect. Immun. 64 (1996) 905-912.
12. S. Miyazaki, N. Kawasaki, W. Kudo and D. Attwood, Comparison of in situ gelling formulation for oral delivery of cimetidine, Int. J. Pharm. 220 (2001) 161-168; DOI: 10.1016/S0378-5173(01)00669-X.
13. United State Pharmacopeia 24 /National Formulary 19, USP Convention, Rockville, MD, 2002.
14. S. A. Agnihotri, S. S. Jawalkar and T. M. Aminabhavi, Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size, and drug release, Eur. J. Pharm. Biopharm. 63 (2006) 249-261; DOI: 10.1016/j.ejpb.2005.12.008.
15. I. Corthesy-Theulaz, N. Portal, M. Glauser, E. Saraga, R. Haas, J. P. Kraehenbushl, A. L. Blem and P. Michetti, Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice, Gastroenterology 109 (1995) 115-121; DOI: 10.1016/0016-5085(95)90275-9.
16. H. Grasdalen and O. Smidsroed, Gellation of gellan gum, Carbohyd. Polym. 7 (1987) 371-393; DOI: 10.1016/0144-8617(87)90004-X.
17. R. Chandrasekaran, L. C. Puigianer, K. L. Joyce and S. Arnotts, The influence of calcium ions, acetate and L-glycerate groups on the gellan double-helix, Carbohyd. Res. 181 (1988) 23-40; DOI: 10.1016/0008-6215(88) 84020-5.
18. R. Chandrasekaran and V. G. Thailambad, Cation interactions in gellan: An x-ray study of the potassium salt, Carbohyd. Polym. 12 (1990) 431-442; DOI: 10.1016/0144-8617(90)90092-7.
19. A. D. Sezer and J. Akbuga, Release characteristics of chitosan treated alginate beads. I. Sustained release of low molecular drug from chitosan treated alginate beads, J. Microencapsul. 16 (1999) 195-203; DOI: 10.1080/026520499288636.
20. P. S. Rajinikanth, C. Sankar and B. Mishra, Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation, Drug Deliv. 10 (2003) 21-28; DOI: 10.1080/713840323.
21. J. Balasubramaniam and J. K. Pandit, Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride, Drug Deliv. 10 (2003) 185-191; DOI: 10.1080/713840402.
22. W. I. Higuchi, Analysis of data on the medicament release from ointments, J. Pharm. Sci. 51 (1962) 802-804.
23. R. W. Korsmeyer, R. Gurney, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.